The Leukemia & Lymphoma Society
1311 Mamaroneck Avenue
White Plains
New York
10605
United States
Tel: 914-949-5213
Fax: 914-949-6691
Website: http://www.leukemia-lymphoma.org/
218 articles about The Leukemia & Lymphoma Society
-
Stemline Therapeutics, Inc. and The Leukemia & Lymphoma Society Announce Collaboration to Accelerate the Development of SL-401 in Hematologic Cancers and Increase Awareness of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
10/29/2013
-
The Leukemia & Lymphoma Society Announces Recipients of the New Idea Grant
10/23/2013
-
The Leukemia & Lymphoma Society Names Dr. Lee Greenberger Chief Scientific Officer
10/3/2013
-
The Leukemia & Lymphoma Society and the Knight Cancer Institute Launch Groundbreaking Collaboration to Improve Outcomes for Acute Myeloid Leukemia Patients
9/17/2013
-
The Leukemia & Lymphoma Society and Affimed Therapeutics AG Partner to Advance AFM13 in a Phase 2 Trial for Refractory and/or Relapsed Hodgkin Lymphoma Patients
9/16/2013
-
The Leukemia & Lymphoma Society Canada Names Christopher Barry its New President
7/8/2013
-
The Leukemia & Lymphoma Society and Johns Hopkins University School of Medicine to Collaborate on a Phase II Clinical Trial to Advance Innovative Immunotherapy for Multiple Myeloma Patients
7/1/2013
-
EHE International and the The Leukemia & Lymphoma Society Showcase Advances in Blood Cancer Research and Patient Access in the Heart of Manhattan
7/1/2013
-
The Leukemia & Lymphoma Society and Dana-Farber Cancer Institute to Bring Clinical Trials to Local Communities
6/7/2013
-
The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene, Inc. Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients
5/23/2013
-
Researchers Funded by The Leukemia & Lymphoma Society Present Innovative Science at American Association for Cancer Research Annual Meeting 2013
4/4/2013
-
The Leukemia & Lymphoma Society Announces Expanded Role for Mark Velleca, M.D., Ph.D., Chief Policy and Advocacy Officer
3/8/2013
-
Quest for Cures: The Leukemia & Lymphoma Society Seeks to Fund Three Critical Areas of Blood Cancer Research
3/1/2013
-
The Leukemia & Lymphoma Society: Impacting Blood Cancers and Beyond
2/19/2013
-
The Leukemia & Lymphoma Society Awards $1.68 Million to Improve Outcomes for Patients With Acute Promyelocytic Leukemia
1/25/2013
-
Curis, Inc. Achieves CUDC-907 Milestones Under Its Agreement With The Leukemia & Lymphoma Society
10/18/2012
-
Constellation Pharmaceuticals and The Leukemia & Lymphoma Society Partner to Develop Novel BET Inhibitor for the Treatment of Hematologic Malignancies
9/20/2012
-
The Leukemia & Lymphoma Society Awards Four Major Grants to Acclaimed Researchers
9/6/2012
-
The Leukemia & Lymphoma Society and Celator Pharmaceuticals, Inc. Announce $5 Million Partnership to Support Phase 3 Development of CPX-351 for AML
7/5/2012
-
The Leukemia & Lymphoma Society Release: Deal Announced Today Between Celgene Corporation and Epizyme, an LLS-partner, Will Help Advance a Therapy for Patients with Mixed Lineage Leukemia
4/27/2012